Form 4 · Filed May 22, 2026, 10:19 PM UTC
TBPH/Theravance Biopharma, Inc.
Grimaud Brett A. — SVP, GEN COUNSEL AND SECRETARY
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 20, 2026 | F | other | 8,829 | $17 | $146,120 | 363,120 |
Source: SEC EDGAR raw filing ↗ · Accession 0001966698-26-000006